Likewise, other studies have seen that CBL increases the amount of BDNF in vitro [74, 114], in animal models of epilepsy [115], and depression [116, 117] and in the serum of human patients with Alzheimer’s disease [118]. The gene discussed is BDNF; the disease is early-onset autosomal dominant Alzheimer disease.